Minerva Neurosciences - 48 Year Dividend History | NERV

Historical dividend payout and yield for Minerva Neurosciences (NERV) since 1971. The current TTM dividend payout for Minerva Neurosciences (NERV) as of July 19, 2019 is $0.00. The current dividend yield for Minerva Neurosciences as of July 19, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.253B $0.000B
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The Company's pipeline will initially target the treatment of schizophrenia, major depressive disorder (MDD), insomnia, and Parkinson's disease. Its product candidates include MIN-101, MIN-117, MIN-202 and MIN-301. Minerva Neurosciences, Inc. is based in Cambridge, MA, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.017B 35.15
Astellas Pharma (ALPMY) Japan $28.057B 13.76
Takeda Pharmaceutical (TAK) Japan $27.185B 7.98
Eisai (ESALY) Japan $15.800B 27.17
Grifols, S.A (GRFS) Spain $15.229B 19.26
IPSEN SA ADR (IPSEY) France $10.783B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $4.938B 17.36